Aging is one single determinant of most diseases. In recent years, the biotechnology industry started using aging biology as a platform for drug discovery to discover and develop potentially blockbuster therapeutics. Dr. Michael Ringel of BCG presented this trend at the 9th ARDD in Copenhagen
Celebrity Strategy Consultant Predicts What Will Be The Most Impactful Area In The Pharmaceutical Industry
